Company: SMNR
Filing Date: 2025-08-13
Form Type: 424B3
Source: 0001193125-25-179226
Chunk: 607

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-08-13
Form: 424B3
Chunk 607
---
 and Analysis be approved for inclusion in New Semnur’s annual reports on Form 10-K, registration statements, New Semnur’s 
 annual meeting proxy statements and information statements.                                                                                                                                     |

Under its charter, the compensation committee may form, and delegate authority to, subcommittees as appropriate. The compensation committee will review, discuss and assess its own performance and composition at least annually. The compensation committee will also periodically review and assess the adequacy of its charter, including its role and responsibilities as outlined in its charter, and recommend any proposed changes to the New Semnur Board for its consideration and approval. The composition and functioning of the compensation committee will comply with all applicable requirements of the Sarbanes-Oxley Act and all applicable SEC rules and Nasdaq Listing Rules. New Semnur intends to comply with future requirements to the extent they become applicable to New Semnur. 383

Nominating and Corporate Governance Committee New Semnur’s nominating and corporate governance committee will consist of Dorman Followwill and Yue Alexander Wu, Ph.D., with Dorman Followwill serving as the chairperson of the committee. Dorman Followwill and Yue Alexander Wu, Ph.D. will each satisfy the independence requirements under the Nasdaq Listing Rules. The responsibilities of the nominating and corporate governance committee are included in its written charter. The nominating and corporate governance committee will act on behalf of the New Semnur Board to fulfill the New Semnur Board’s responsibilities in overseeing all aspects of the company’s nominating and corporate governance functions. The responsibilities of the nominating and corporate governance committee will include, among others:

| • |     | making recommendations to the New Semnur Board regarding corporate governance issues; |

| • |     | identifying, reviewing and evaluating candidates to serve as directors (consistent with criteria approved by the 
 New Semnur Board);                                                                                               |

| • |     | determining the minimum qualifications for service on the New Semnur Board; |

| • |     | reviewing and evaluating incumbent directors; |

| • |     | instituting and overseeing director orientation and director continuing education programs; |

| • |     | serving as a focal point for communication among candidates to the New Semnur Board, non-committee directors and New Semnur’s management; |

| • |     | recommending to the New Semnur Board for selection candidates to serve as nominees for director for the annual 
 meeting of stockholders and to fill any vacancies on the New Semnur Board and any